Skip to main content
SHINECO, INC. logo

SHINECO, INC. — Investor Relations & Filings

Ticker · SISI ISIN · US8245673095 LEI · 254900BYEC9UH1OEUR67 US Manufacturing
Open in API
Filings indexed 376 across all filing types
Latest filing 2025-11-20 Delisting Announcement
Country US United States of America
Listing US SISI

About SHINECO, INC.

https://www.biosisi.com

Shineco, Inc. is a biotechnology and healthcare company specializing in advanced life sciences and medical diagnostics. The company's core business encompasses the development of induced pluripotent stem cell (iPSC) technology platforms and extracellular vesicle-derived products. Additionally, through its subsidiaries, Shineco engages in the research, development, manufacturing, and distribution of a comprehensive portfolio of Point-of-Care Testing (POCT) diagnostic products and related medical devices. These diagnostic solutions address various disease categories and are marketed internationally.

Recent filings

Filing Released Lang Actions
Delisting Announcement 2025
Delisting Announcement
2025-11-20 English
8-K
Delisting Announcement Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated October 1, 2025. It details the company's receipt of a delisting notice from Nasdaq due to non-compliance with the minimum bid price rule, the subsequent hearings and appeals, legal proceedings initiated by the company against Nasdaq, and the eventual suspension of trading of the company's stock. The content focuses on the delisting event, legal actions, and regulatory communications related to the listing status of the company's securities. There are no financial statements or earnings data presented, nor is this a proxy, management discussion, or other report type. The primary subject is the official notice and explanation of the delisting event and related legal proceedings. Therefore, the document fits the definition of a Delisting Announcement (DLST). The document length and detail confirm it is the announcement itself, not a brief notice or report publication announcement.
2025-10-08 English
NT 10-K
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company, Shineco, Inc., is unable to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2025, by the deadline due to delays in completing financial statements and audit. The document does not contain the actual 10-K report or financial data but is a notification about the delay in filing the 10-K. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a compliance document notifying the SEC of a late filing rather than the report itself.
2025-09-29 English
8-K
Delisting Announcement Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details a notice of delisting or failure to satisfy a continued listing rule by Nasdaq, including the timeline of events, hearings, and legal actions related to the potential delisting of the company's stock. The document does not contain financial statements or detailed financial analysis but focuses on regulatory and listing status updates. This matches the definition of a Delisting Announcement (DLST). The document length is 8656 characters, which is sufficient for a detailed announcement rather than a brief notice. Therefore, the appropriate classification is DLST with high confidence.
2025-07-31 English
DEF 14C
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14C Information Statement filed with the SEC, specifically a definitive information statement pursuant to Section 14(c) of the Securities Exchange Act of 1934. It details a corporate action approved by written consent of the majority of shareholders regarding a reverse stock split to meet Nasdaq listing requirements. The document explicitly states it is an Information Statement and not a proxy solicitation or meeting notice. It provides detailed information about the stockholders' consent, reasons for the reverse stock split, and the board's discretion to implement it. This type of filing is used to inform shareholders of corporate actions without a meeting and is classified as a Proxy Solicitation & Information Statement (PSI). The document is substantive and not merely an announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). Therefore, the correct classification is PSI with high confidence.
2025-07-15 English
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes an unregistered sale of equity securities, specifically the sale of 18 million shares at $0.75 per share, resulting in gross proceeds of $13.5 million. This is a clear update on the company's financing activities, specifically a capital raise through equity issuance. The document is not a full financial report, earnings release, or management discussion, but rather a specific event disclosure related to capital/financing. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 4495 characters, which is consistent with a typical 8-K filing for such an event, not a full report or announcement of a report publication.
2025-07-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.